This study was undertaken to determine 1) whether a combined radionuclide-hemodynamic technique could define the right ventricular end-systolic pressure-volume relation (RV ESPVR) in the clinical setting, 2) whether the human RV ESPVR defined by maximal elastance is linear and responsive to inotropic interventions, and 3) whether more easily measured modifications of the ESPVR are reliable substitutes as an index of RV function. Eight patients with normal RV function were studied with simultaneous micromanometer RV pressure measurements and radionuclide ventriculography to construct RV pressure-volume loops. Data were collected at baseline and after at least two alterations in loading conditions with nitroglycerin, phenylephrine, or saline. End systole was defined by maximal elastance (E(t) = P(t)I [V(t) -VO]). Data were also obtained during administration of dobutamine in four patients and after atrial pacing tachycardia in one patient. The RV ESPVR defined by maximal elastance was highly linear (r=0.988-0.999) throughout the range of pressures and volumes tested. Furthermore, the linear correlations were significantly higher (p<0.005), and the linear regression standard error of the estimate (SEE) was significantly lower (p<0.005) for the RV ESPVR defined by maximal elastance compared with modifications of the ESPVR with the ratio of pulmonary artery-dicrotic notch pressure or RV peak pressure to end-ejection volume. Dobutamine or atrial pacing tachycardia produced a leftward shift of the entire RV pressure-volume loop, and in each patient (five of five), the point of maximal elastance fell outside the 95% confidence interval defined by the baseline ESPVR. However, because of the larger SEE, the leftward shift with modifications of the ESPVR was not statistically significant in any patient by the pulmonary artery-dicrotic notch pressure: end-ejection volume ratio and was significant in only one of five patients by the RV peak pressure: end-ejection volume ratio (p<0.03). Therefore, it appears that the steady-state RV ESPVR defined by maximal elastance in patients with normal RV function is responsive to alterations in inotropic state and is more sensitive to alterations in RV function than the frequently used, more easily measured modifications of the RV ESPVR. (Circulation 1988;78:81-91) T he concept of the left ventricular (LV) endsystolic pressure-volume relation (ESPVR) has evolved substantially in complexity in recent years. However, there is a large body of experimental and clinical data showing that the LV ESPVR is relatively load independent and sensitive to changes in LV contractility and, hence, can serve as a clinically useful index of LV function. 1-15 In the isolated heart, the right ven-
T he concept of the left ventricular (LV) endsystolic pressure-volume relation (ESPVR) has evolved substantially in complexity in recent years. However, there is a large body of experimental and clinical data showing that the LV ESPVR is relatively load independent and sensitive to changes in LV contractility and, hence, can serve as a clinically useful index of LV function. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] In the isolated heart, the right ven-tricular (RV) ESPVR also appears to be load independent and responsive to inotropic changes. 16 However, there have been few studies of the RV ESPVR in humans. '7-'9 Although Sagawal has defined end systole as the point when the active contractile process peaks, identified as the time of maximal elastance, previous clinical reports of RV ESPVR17-19 have used pulmonary artery (PA)-dicrotic notch or peak RV pressure and minimum radionuclide-derived RV volume as estimates of RV end-systolic pressure and volume, respectively, because they are relatively easy to measure. For the LV, the ESPVRs derived with comparable pressure and volume surrogates correlate reasonably well with the ESPVRs determined from maximal elastance. 20, 21 However, there are theoretical considerations that may limit the applicability of these surrogates to the RV.
Normally, LV ejection ends shortly after end systole defined by maximal elastance, but this is not true when peripheral resistance is low. 122 as in the pulmonary circulation. Indeed, Maughan et al16 have demonstrated that RV ejection continues well beyond end systole defined by maximal elastance. The relation between RV maximal elastance and these other indexes of end systole has not been previously examined in humans. Therefore, the present study was undertaken to determine I) whether a combined radionuclide-hemodynamic approach can be clinically applied to the study of the RV ESPVR, 2) whether the human RV ESPVR defined by maximal elastance is sensitive to changes in contractile state, and 3) whether more easily measured indexes of RV end systole are reliable substitutes when determining ESPVR as a measure of RV function.
Patients and Methods Patient Population
The study group consisted of eight patients (six male and two female) scheduled to undergo diagnostic cardiac catheterization for suspected coronary artery or valvular heart disease. At catheterization, four patients had normal findings, two had isolated left anterior descending coronary artery disease (50% and 80% luminal diameter narrowing), one had mild aortic stenosis (mean gradient= 10 mm Hg), and one had moderate aortic insufficiency (Table 1 ). All patients had normal baseline right heart hemodynamics and normal RV contraction by radionuclide ventriculography (see below). The mean age was 55± 11 (± SD) years. Cardiac medications at the time of admission included nitrates (one of eight), /3-blockers (two of eight), and diuretics (one of 89  89  90  85  90  85  132  71  71  71  71   71  74  74  74  91  89  90  90  89  89  89  94  94  94  94  83  83  83 46  49  49  30  27  29  53  44  60  74  56  70  74  73  58  47  51  35  76  60  63  65  45  43  62  92  82  62  59   11  10  13  22  11  9  24  17  10  24  29  28  7  14  2  22  7  15  30  16  6  10  21  17  14  22  15  17  23  11   27  21  20  29  14  11  21  31  21  41  50  21  34  39  29  32  19  26  18  41  30  35  33  28  24  34  45  34  31  15   9  6  13  16  13  8  13  15  5  18  20  15  7  8  4  19  9  12  26  14  5  13  20  15  13  18  18  15  15  14   12  11  15  27  17  12  26  20   11  25  29  32  13  20  11  30  16  20  32  21  11  18  26  21  17  25  26  24  20  24   21  16  19  27  13  9  17  26  20  37  51  17  34  39  29  32  16  26  11  39  29  34  32  24   20   34  44  34  31  11   43   35  64  158  79  53  58  120  100  99  116  72  83  74  67  91  34  100  143  68  41  120  72  68  64  104  82  82  74  47 CAD, coronary artery disease; HR, heart rate; RVEF, right ventricular ejection fraction; EDVI, end-diastolic volume index; ESP, end-systolic pressure; ESVI, end-systolic volume index; PA-DN, pulmonary artery-dicrotic notch pressure; RV-PP, right ventricular peak pressure; EEVI, end-ejection volume index; PVR, pulmonary vascular resistance; AS, aortic stenosis; LAD, left anterior descending artery stenosis; AI, aortic insufficiency. eight). At the time of study, no patient had evidence of recent acute myocardial infarction, unstable angina pectoris, congestive heart failure, ventricular ectopy, cardiomyopathy, or right heart valvular pathology. slant-hole collimator was positioned over the heart in the left anterior oblique view that best separated the RV and LV as well as the right atrium and RV. Gated images were collected with a 64 x 64-matrix in 32 frames/cycle for 3-8 minutes. The exact time of each collection was recorded, and a blood sample was obtained at the midpoint of each study. Radionuclide ventriculograms and simultaneous pressure measurements were recorded at baseline and after sequential alterations in loading conditions (see below). Analysis RV time-activity curves from serial backgroundcorrected radionuclide ventriculograms were analyzed in each patient with an operator-drawn fixed end-diastolic RV region of interest. The enddiastolic image was used to identify the septal border of the ventricle, while the stroke volume image and isocontour fitting were used to identify the inferior and free walls of the RV. A fixed region of interest was chosen because it minimizes operator error and variability for frame-by-frame analysis of ventricular counts. Baseline absolute RV enddiastolic volume (EDV) was calculated from baseline radionuclide ejection fraction (EF) and thermodilution stroke volume (SV = cardiac output/heart rate): RVEDV = SV/EF. Relative changes in RV volumes between baseline and postloading radionuclide ventriculograms were determined by correcting RV counts for acquisition time, physical decay, and biological clearance. Acquisition time was calculated as the product of frame duration and number of cardiac cycles that were counted. Physical decay was corrected by recording the duration of time between each study. Biological clearance of the tracer was determined, with a well counter, from changes in counts per second per 100 microliters sample of blood obtained at the midpoint of each study.
Experimental Protocol
Baseline data collection. Before data collection, the temporary atrial pacemaker was set to capture approximately 5 beats/min above resting rate to minimize changes in heart rate during load changes. After baseline radionuclide and hemodynamic measurements were obtained, loading conditions were altered with intravenous infusion of nitroglycerin or phenylephrine (starting at 10 gg/min) or 0.9% saline boluses of 250-300 ml infused intravenously during 2-3 minutes. Infusions were titrated to produce changes in RV systolic pressure of 4-8 mm Hg or at least a 15% change from baseline. In four patients, more than one type of intervention was used to change load (Table 1) .
At the new steady-state loading condition, a radionuclide ventriculogram with simultaneous hemodynamic measurements was recorded. In this manner, resting data were collected during three or four steady-state loading conditions in each patient.
With atrial pacemaker capture (described above), heart rate showed no change in six patients and less than 6% change in two patients in response to load alterations (Table 1) .
After completion of the resting data collections, a subgroup of four patients (all with normal coronary arteries) received an intravenous infusion of dobutamine (10 ,ug/kg/min), and repeat radionuclide and hemodynamic data were again collected. In one additional patient (with isolated left coronary disease), atrial pacing tachycardia was produced to 85% of age-predicted maximal heart rate (132 beats/min), and repeat radionuclide and hemodynamic data were collected. In this patient, no chest pain or ischemic ST depression developed at peak pacing. In all cases, neither the patient nor gamma camera was moved between data collections.
Pressure-Volume Relations
Calculation ofEiiax and Vo from analysis of maximal elastance. Pressure-volume loops were generated for each radionuclide ventriculogram. RV pressure tracings encompassing one respiratory cycle (usually 6-9 beats) were digitized to 128 points/ cardiac cycle. End diastole for each cardiac cycle was defined as the onset of the gating signal of the nuclear medicine cardiology camera/computer that was superimposed upon the pressure tracings. The gating signal represents the moment when the imaging computer recognizes the electrocardiographic QRS signal and begins collecting data for that cardiac cycle. The serial RV pressure tracings were then averaged point by point for each of the 128 points per cardiac cycle by computer (Endeco Medical, Marion, Massachusetts), resulting in a single signal-averaged RV pressure tracing for a given data acquisition. The 32-frame RV radionuclide ventriculogram time-activity curve was digitized, with linear interpolation, to 128 points. The average RV pressure and time-activity curves were then smoothed with a five-point weighted low-pass filter. After the curves were synchronized to end diastole, pressure-volume loops were plotted from 128 pressure-volume coordinates throughout the cardiac cycle. The time interval between data points depended upon the cardiac cycle duration and varied between 3.5 and 6.6 msec. The slope (Emax) and volume intercept (VO) of the ESPVR were determined from the baseline and postloading pressurevolume loops. End systole was defined as the time of maximal elastance, that is, the point in time (t) in a given cardiac cycle at which the elastance was maximal according to the formula: E(t)= P(t)/[V(t) -VOl, where VO = volume axis intercept of the ESPVR. To determine the end-systolic pressurevolume line, the method of Kono and colleagues21 was used: VO was first assumed to be zero, and the maximal pressure:volume ratio was calculated for each loading condition. A least-squares linear regression was then applied, and an initial estimate of VO was defined as the volume intercept of this regression line. With the initial VO, the maximal pressure:
volume ratio was recalculated for each loading condition, and a new linear regression and VO were obtained. This procedure was iterated until VO changed less than 1%.
Because only one data collection, and hence only one pressure-volume loop, was generated from radionuclide-hemodynamic data obtained during dobutamine infusion or atrial pacing tachycardia, Statistical Analysis Reproducibility of volume calculations from enddiastolic and end-systolic counts was analyzed by correlating duplicate measurements and by computing a coefficient of variability (defined as the ratio of the mean difference between these duplicate measurements to the mean end-diastolic or end-systolic volume, expressed as a percentage).
As a further assessment of the accuracy of our radionuclide RV volume calculations, we used linear regression analysis to relate radionuclidederived RV stroke volume to thermodilutionderived RV stroke volume. The data collected during baseline conditions (before loading conditions were altered) for each patient were omitted from analysis of RV stroke volume regression since the baseline thermodilution and radionuclide stroke volumes were defined to be equal to calculate the baseline absolute RV end-diastolic volume.
To compare the goodness of fit of the ESPVR defined by different methods, the correlation coefficient (r value) and the standard error of the estimate (SEE) for each linear ESPVR defined by maximal elastance and by modifications of the ESPVR were compared with repeated-measures analysis of variance followed by paired t tests with Bonferroni's corrections. A similar analysis was used to compare end-systolic RV pressures and volumes determined from maximal elastance with estimates with modifications of the ESPVR. Finally, linear regression was used to correlate Emax and VO with the slope and volume-intercepts defined by modifications of the RV ESPVR. In patients receiving dobutamine or undergoing atrial pacing tachycardia, a significant change in the RV ESPVR was defined as a shift in the point of maximal elastance (or estimate of maximal elastance) beyond the 95% confidence interval defined by the resting linear ESPVR (determined from baseline and postloading data). Differences in sensitivity for detecting significant changes in the ESPVR defined by the different methods were compared by x2 analysis.
Results

Reproducibility and Accuracy of RV Volume Determination
For duplicate measures of end-diastolic and endsystolic volumes, the coefficient of variability was 1.4% and 1.2%, respectively, with both correlation coefficients (r) equal to 0.99. Radionuclide-derived and thermodilution-derived RV stroke volumes were highly correlated (r= 0.97, SEE = 3.8 ml, p<0.0001) (Figure 1 (Figures 2 and 3) . In one patient, some loops showed late peaking of RV pressures toward the point of maximal elastance (Figure 4) . The relation between the point of maximal elastance and end-ejection (i.e., the time of minimum volume) was variable. In two patients (1 and 7), ejection continued well beyond end systole defined by maximal elastance (Figure 2) , while in patient 4 end ejection coincided with end systole. In others, the relation varied even within the same patient as loading conditions were altered. Overall, the RV end-ejection volume was significantly smaller than end-systolic volume defined by maximal elastance (Av = 2 + 2 ml/m2, VOLUME PRESSURE p<0.OOl) ( Table 1) . This difference between RV end-systolic and end-ejection volume showed a weak but significant negative correlation with pulmonary vascular resistance (r = -0.50, p<O.01) and RV peak systolic pressure (r= -0.36, p<0.05). In addition, the PA-dicrotic notch pressure was significantly lower (A= 3 + 3 mm Hg, p<0.001), and the RV peak pressure was significantly higher (A = 4 + 3 mm Hg, p<0.001) than end-systolic pressure defined by maximal elastance ( Table 1) . The difference between RV end-systolic pressure and PA-dicrotic notch pressure or RV peak pressure showed no significant correlation with either pulmonary vascular resistance or RV peak systolic pressure.
The ESPVR defined by points of maximal elastance was highly linear throughout the range of pressures and volumes tested with r values ranging from 0.988 to 0.999 (Figures 2-5 ). Furthermore, for individual patients, the point of maximal elastance during steady-state alterations in loading conditions produced by nitroglycerin appeared to lie on the same ESPVR line defined by load alterations produced by phenylephrine (Figure 3 ) or saline loading (Figure 4) (Table 2) . Furthermore, the r values were statistically significant in seven of eight patients when defined by maximal elastance compared with zero of eight patients when defined by the alternative methods (p<O.OOO1). There were no significant correlations between Emax (determined by maximal elastance) and the slope of the RV ESPVR defined by these modifications (Table 3) . Similarly, there was no significant correlation between VO calculated with maximal elastance and the volume intercepts defined by modifications of the ESPVR.
Effect of Inotropic Interventions
When the RV ESPVR was defined by maximal elastance, dobutamine caused a significant leftward shift (Figure 4 ) in each of the four patients (i.e., the point of maximal elastance lay outside of the 95% confidence interval of the resting linear ESPVR, Figure 5A ). In fact, the entire loop was shifted leftward in each patient such that the pressurevolume coordinates for at least the last third of ejection lay outside the 95% confidence interval of the resting linear ESPVR defined by maximal elastance. However, when the RV ESPVR was defined with PA-dicrotic notch pressure: end-ejection volume or RV peak pressure: end-ejection volume ratios, the leftward shift was not significant in any patient ( Figures 5B and SC) because of the larger SEE (see above; Table 2 ). Compared with the resting ESPVR, tachycardia caused the point of maximal elastance to be significantly shifted leftward ( Figure 6 ). Similar to dobutamine, the entire loop during pacing tachycardia was shifted leftward such that the pressure-volume coordinates of the last third of ejection were beyond the 95% confidence interval of the resting ESPVR. When analysis was performed with RV peak pressure/end-ejection volume ratio, rather than maximal elastance, the leftward shift remained significant. However, a significant shift was not observed with the PA-dicrotic notch pressure/end-ejection volume ratio relation.
The sensitivity for detecting a change in RV function during dobutamine or pacing tachycardia was significantly greater (p<0.03) when analysis was performed with maximal elastance (five of five) compared with either PA-dicrotic notch pressure: end-ejection volume ratio (zero of five) or peak RV pressure: end-ejection volume ratio (one of five). Discussion This study demonstrates that a combined radionuclide-hemodynamic technique can be used in humans to analyze the RV ESPVR derived from full RV pressure-volume loops. With this technique, the ESPVR defined by maximal elastance is highly linear over a physiological range of pressures and volumes in patients with normal RV function and is responsive to changes in RV function produced by positive inotropic interventions with dobutamine or atrial pacing tachycardia. Furthermore, the linear regression used to determine the RV ESPVR has a higher correlation coefficient and lower SEE when defined by maximal elastance than when surrogates derived from modifications of the ESPVR are used. This results in a greater sensitivity to changes in RV function produced by inotropic alterations.
RV Pressure-Volume Diagram
Previous studies have shown that the LV pressurevolume diagram has a rectangular shape with pressure peaking late during ejection.4,10,17 In contrast, we found that RV pressure-volume loops were generally more triangular with early peaking of pressure. This is consistent with observations of Maughan and colleagues16 using an isolated heart preparation. These investigators also reported that RV volume continued to decrease well beyond end systole defined by maximal elastance. We found a variable relation between end-systolic and endejection volume, not only between patients, but even within individual patients. This variability in part may be related to interpatient and intrapatient differences in RV loading conditions since the difference between end-systolic and end-ejection volume tended to be inversely related to pulmonary vascular resistance and RV peak systolic pressure.
Modifications of RV ESPVR
Previous studies of RV pressure-volume relations have used PA-dicrotic notch (or RV peak pressure) and end-ejection volume as surrogates of RV endsystolic pressure and volume, respectively, because ofthe relative ease in making such measurements. [17] [18] [19] However, in the present study, the ESPVR defined by these estimates of RV end systole had an inferior goodness of fit and consequently had less statistical power to detect changes in RV function produced by inotropic interventions compared with the ESPVR defined by maximal elastance.
There are probably several reasons for this observation. First, PA-dicrotic notch pressure (or RV peak pressure) and end-ejection volume do not faithfully reflect end-systolic pressure and volume defined by maximal elastance that, as conceived by Sagawa," 2 more accurately reflects the peak active contractile process. Although in an analogous study of the LV, the ESPVR defined by aortic-dicrotic notch pressure and LV end-ejection volume corresponded well to the ESPVR derived from maximal elastance,20 this observation is not directly applicable to the RV. While LV ejection usually ends shortly after end systole defined by maximal elastance, Sagawal has pointed out that this relation is coincidental, dependent upon ambient loading con- Figures 3, 4, and 6 . Second, and more importantly, even if a change in external forces did occur during diastole as a result of the interventions performed in our study, such effects are much less important during systole since measured pericardial pressure over the ventricles is very small at end systole29 and since transseptal pressure influences are minimal in the absence of pericardial constraint.30,31 Finally, it is of interest to note that during atrial pacing tachycardia, in contrast to dobutamine stimulation, the entire diastolic pressure-volume curve was shifted upward (Figure 6 ). The cause of this change is unclear but may be due to impaired relaxation. 
Radionuclide Methods
Absolute RV volumes were not determined directly from radionuclide data. Although possible, this requires complicated calculations and estimates of attenuation factors to correct for differences in body constitution as well as the distance between the RV center of mass and the camera. However, since each patient served as his own control, obviating the need for absolute volumes, only relative changes in RV volumes (determined from corrected count-based data) were determined for each patient. Absolute RV volumes under each altered loading condition were created with the baseline thermodilution stroke volume and radionuclide ejection fraction, and subsequent relative changes in corrected RV counts.
In addition, a fixed region of interest was used to generate RV time-activity curves to eliminate variance and error introduced when separate regions of interest are chosen for each frame of the cardiac cycle. This theoretically could lead to a systematic underestimation of stroke volume because of overlying right atrial activity. However, a slant-hole collimator was used to view the heart cranially and greatly reduce the potential for overlap. Although a slight tendency toward underestimation of stroke volume by radionuclide ventriculography (Figure 1 ) was found, this was not a statistically significant effect since the slope and y-intercept of the regression relating radionuclide to thermodilution stroke volume were not different from I and 0, respectively.
Conclusions
The human RV ESPVR defined by maximal elastance, with a combined radionuclide-hemodynamic technique, is linear over a physiological range of pressures and volumes in patients with normal RV function and is responsive to changes in RV function produced by inotropic interventions. Modifications of the ESPVR with PA-dicrotic notch pressure or end-ejection volume underestimate end-systolic pressure and volume, respectively, as determined from maximal elastance. Finally, the RV ESPVR defined by maximal elastance is more sensitive to alterations in RV function than modifications of the ESPVR with the ratio of PA-dicrotic notch pressure or RV peak pressure to end-ejection volume.
